Seattle, Washington
CNS clinical trials in Seattle, WA
42 CNS studies are recruiting participants at sites in Seattle as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Seattle at a glance
- 42 studies are recruiting at a site in Seattle.
- By phase: Phase 1 (2), Phase 1/2 (2), Phase 2 (2), Phase 2/3 (1), Phase 3 (17), Phase 4 (1), No phase (11), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (25), university, hospital or other (14), government (3).
- By research area: Depression (13), Multiple Sclerosis (9), Parkinson's Disease (7), Epilepsy (6), Migraine (4), ADHD (3).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Seattle
Basic details from each study's public record (the 30 most recently updated of 42). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- No phase
- Ages 12 to 22
- All sexes
- Sponsor
- Michigan State University
- Study site
- Seattle Children's Hospital
- Registry record
- NCT06232304 · updated
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study site
- Seattle Neuropsychiatric Treatment Center
- Registry record
- NCT06793397 · updated
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Washington
- Study site
- University of Washington
- Registry record
- NCT07637097 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- Seattle Neuropsychiatric Treatment Center
- Registry record
- NCT07002034 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- Seattle Neuropsychiatric Treatment Center
- Registry record
- NCT03887715 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Study site
- Seattle Children's Hospital
- Registry record
- NCT07048574 · updated
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- VA Puget Sound Health Care System Seattle Division, Seattle, WA
- Registry record
- NCT07226232 · updated
Morphine or Ketamine for Analgesia
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Columbia University
- Study site
- Seattle Children's Hospital
- Registry record
- NCT06835504 · updated
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Draig Therapeutics Ltd
- Study site
- Draig Clinical Site
- Registry record
- NCT07610473 · updated
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Yale University
- Study site
- Seattle NTC
- Registry record
- NCT06713616 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Seattle, WA on ClinicalTrials.gov.
ADHD studies recruiting in Seattle
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Seattle Children's Hospital
- Registry record
- NCT03047369 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Seattle, WA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Seattle
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study sites
- University of Washington Medical Center · Virginia Mason Medical Center
- Registry record
- NCT02071134 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Fred Hutchinson Cancer Center ( Site 0042)
- Registry record
- NCT06841354 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Fred Hutchinson Cancer Center ( Site 0069)
- Registry record
- NCT06966700 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Swedish Cancer Institute ( Site 0143)
- Registry record
- NCT06623422 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Seattle, WA on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Seattle
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT05877963 · updated
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study sites
- Multiple Sclerosis Center at Northwest Hospital · Multiple Sclerosis Center, Swedish Neuroscience Institute
- Registry record
- NCT04047628 · updated
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Phase 1
- Ages 18 to 75
- All sexes
- Sponsor
- Kite, A Gilead Company
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07304154 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- University of Washington MS Clinic
- Registry record
- NCT07225504 · updated
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Phase 1/2
- Ages 18 to 65
- All sexes
- Sponsor
- Tr1X, Inc.
- Study site
- Providence Swedish
- Registry record
- NCT07477639 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Seattle, WA on ClinicalTrials.gov.
Epilepsy studies recruiting in Seattle
Biomarker Targeted Stimulation for Epileptiform Events
- No phase
- Ages 7 and older
- Male participants
- Sponsor
- Cadence Neuroscience
- Study site
- Seattle Children's Hospital
- Registry record
- NCT06424977 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- University of Washington, Regional Epilepsy Center at Harborview Medical Center
- Registry record
- NCT05667142 · updated
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Study site
- Seattle Children's Hospital
- Registry record
- NCT07531745 · updated
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study site
- University of Washington Regional Epilepsy Center
- Registry record
- NCT05135091 · updated
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Phase 3
- Ages 2 and older
- All sexes
- Sponsor
- Epygenix
- Study site
- Seattle Children's Hospital
- Registry record
- NCT04462770 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Seattle, WA on ClinicalTrials.gov.
Migraine studies recruiting in Seattle
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Seattle Clinical Research Center
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Seattle Clinical Research Center
- Registry record
- NCT07674654 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Seattle Children's Hospital · Seattle Children's Hospital Investigational Drug Services
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Seattle Children's Hospital · Seattle Children's Hospital Investigational Drug Services
- Registry record
- NCT04743141 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Seattle, WA on ClinicalTrials.gov.
Ask about studies near Seattle
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections